Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet.

Comino I, Segura V, Ortigosa L, Espín B, Castillejo G, Garrote JA, Sierra C, Millán A, Ribes-Koninckx C, Román E, Rodríguez-Herrera A, Díaz J, Silvester JA, Cebolla Á, Sousa C.

Aliment Pharmacol Ther. 2019 Jun;49(12):1484-1492. doi: 10.1111/apt.15277. Epub 2019 May 10.

PMID:
31074004
2.

Celiac Immunogenic Potential of α-Gliadin Epitope Variants from Triticum and Aegilops Species.

Ruiz-Carnicer Á, Comino I, Segura V, Ozuna CV, Moreno ML, López-Casado MÁ, Torres MI, Barro F, Sousa C.

Nutrients. 2019 Jan 22;11(2). pii: E220. doi: 10.3390/nu11020220.

3.

The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but Provides Better Gut Microbiota Profile.

Haro C, Villatoro M, Vaquero L, Pastor J, Giménez MJ, Ozuna CV, Sánchez-León S, García-Molina MD, Segura V, Comino I, Sousa C, Vivas S, Landa BB, Barro F.

Nutrients. 2018 Dec 12;10(12). pii: E1964. doi: 10.3390/nu10121964.

4.

Tritordeum: a novel cereal for food processing with good acceptability and significant reduction in gluten immunogenic peptides in comparison with wheat.

Vaquero L, Comino I, Vivas S, Rodríguez-Martín L, Giménez MJ, Pastor J, Sousa C, Barro F.

J Sci Food Agric. 2018 Apr;98(6):2201-2209. doi: 10.1002/jsfa.8705. Epub 2017 Nov 9.

PMID:
28963718
5.

Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.

Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Montes-Cano MA, Espín B, Galera A, Valverde J, José Girón F, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C.

Am J Gastroenterol. 2017 Jul;112(7):1208. doi: 10.1038/ajg.2017.110. Epub 2017 Apr 11.

PMID:
28397876
6.

Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients.

Moreno ML, Rodríguez-Herrera A, Sousa C, Comino I.

Nutrients. 2017 Jan 6;9(1). pii: E46. doi: 10.3390/nu9010046. Review.

7.

Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.

Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Antonio Montes-Cano M, Espín B, Galera A, Valverde J, Girón FJ, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C.

Am J Gastroenterol. 2016 Oct;111(10):1456-1465. doi: 10.1038/ajg.2016.439. Epub 2016 Sep 20. Erratum in: Am J Gastroenterol. 2017 Jul;112(7):1208.

8.

Identification and molecular characterization of oat peptides implicated on coeliac immune response.

Comino I, Bernardo D, Bancel E, de Lourdes Moreno M, Sánchez B, Barro F, Šuligoj T, Ciclitira PJ, Cebolla Á, Knight SC, Branlard G, Sousa C.

Food Nutr Res. 2016 Feb 5;60:30324. doi: 10.3402/fnr.v60.30324. eCollection 2016.

9.

Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.

Moreno ML, Cebolla Á, Muñoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro Á, León F, Rodríguez-Herrera A, Sousa C.

Gut. 2017 Feb;66(2):250-257. doi: 10.1136/gutjnl-2015-310148. Epub 2015 Nov 25.

10.

Role of oats in celiac disease.

Comino I, Moreno Mde L, Sousa C.

World J Gastroenterol. 2015 Nov 7;21(41):11825-31. doi: 10.3748/wjg.v21.i41.11825. Review.

11.

Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins.

Barro F, Iehisa JC, Giménez MJ, García-Molina MD, Ozuna CV, Comino I, Sousa C, Gil-Humanes J.

Plant Biotechnol J. 2016 Mar;14(3):986-96. doi: 10.1111/pbi.12455. Epub 2015 Aug 24.

12.

Identification and in vitro reactivity of celiac immunoactive peptides in an apparent gluten-free beer.

Real A, Comino I, Moreno Mde L, López-Casado MÁ, Lorite P, Torres MI, Cebolla Á, Sousa C.

PLoS One. 2014 Jun 25;9(6):e100917. doi: 10.1371/journal.pone.0100917. eCollection 2014.

13.

Reduced-gliadin wheat bread: an alternative to the gluten-free diet for consumers suffering gluten-related pathologies.

Gil-Humanes J, Pistón F, Altamirano-Fortoul R, Real A, Comino I, Sousa C, Rosell CM, Barro F.

PLoS One. 2014 Mar 12;9(3):e90898. doi: 10.1371/journal.pone.0090898. eCollection 2014.

14.

The gluten-free diet: testing alternative cereals tolerated by celiac patients.

Comino I, Moreno Mde L, Real A, Rodríguez-Herrera A, Barro F, Sousa C.

Nutrients. 2013 Oct 23;5(10):4250-68. doi: 10.3390/nu5104250. Review.

15.

Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease.

Real A, Comino I, de Lorenzo L, Merchán F, Gil-Humanes J, Giménez MJ, López-Casado MÁ, Torres MI, Cebolla Á, Sousa C, Barro F, Pistón F.

PLoS One. 2012;7(12):e48365. doi: 10.1371/journal.pone.0048365. Epub 2012 Dec 17.

16.

Significant differences in coeliac immunotoxicity of barley varieties.

Comino I, Real A, Gil-Humanes J, Pistón F, de Lorenzo L, Moreno Mde L, López-Casado MÁ, Lorite P, Cebolla A, Torres MI, Barro F, Sousa C.

Mol Nutr Food Res. 2012 Nov;56(11):1697-707. doi: 10.1002/mnfr.201200358. Epub 2012 Sep 12.

PMID:
22968973
17.

Immunological determination of gliadin 33-mer equivalent peptides in beers as a specific and practical analytical method to assess safety for celiac patients.

Comino I, Real A, Moreno Mde L, Montes R, Cebolla A, Sousa C.

J Sci Food Agric. 2013 Mar 15;93(4):933-43. doi: 10.1002/jsfa.5830. Epub 2012 Aug 6.

PMID:
22886585
18.

Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Comino I, Real A, Vivas S, Síglez MÁ, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrera A, Cebolla A, Sousa C.

Am J Clin Nutr. 2012 Mar;95(3):670-7. doi: 10.3945/ajcn.111.026708. Epub 2012 Jan 18.

19.

A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity.

Caminero A, Nistal E, Arias L, Vivas S, Comino I, Real A, Sousa C, de Morales JM, Ferrero MA, Rodríguez-Aparicio LB, Casqueiro J.

Eur J Nutr. 2012 Apr;51(3):293-9. doi: 10.1007/s00394-011-0214-3. Epub 2011 Jun 14.

PMID:
21671042
20.

Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease.

Comino I, Real A, de Lorenzo L, Cornell H, López-Casado MÁ, Barro F, Lorite P, Torres MI, Cebolla A, Sousa C.

Gut. 2011 Jul;60(7):915-22. doi: 10.1136/gut.2010.225268. Epub 2011 Feb 12.

Supplemental Content

Loading ...
Support Center